CollPlant Biotechnologies Ltd. (CLGN) Financials

CLGN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 37.6 million 5.2 million
2023-06-30 41.6 million 5.5 million
2023-03-31 35.8 million 5.9 million
2022-12-31 35.8 million 5.9 million

CLGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 6.5 million 521000
2023-06-30 -4.1 million 338000
2023-03-31 -3.6 million 514000
2022-12-31 -3.6 million 514000

CLGN Net Income

No data available :(

CLGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 29.0 million - 3.1 million
2023-06-30 22.3 million - 3.3 million
2023-03-31 26.5 million - 3.5 million
2022-12-31 26.5 million - 2.9 million

CLGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 11.4 million
2023-06-30 11.8 million
2023-03-31 11.3 million
2022-12-31 11.3 million

CLGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 243000 2.7 million 1.7 million -
2023-06-30 337000 2.6 million 1.3 million -
2023-03-31 145000 2.1 million 1.5 million -
2022-12-31 145000 2.1 million 2.0 million -

CLGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 43000 278000
2023-06-30 10.2 million 615000
2023-03-31 433000 325000
2022-12-31 433000 325000

CLGN

Price: $5.85

52 week price:
4.22
8.90

Earnings Per Share: -0.62 USD

P/E Ratio: -9.35

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 28000

Market Capitalization: 60.1 million

Links: